O36.1115 Maternal care for Anti-A sensitization, first trimester, fetus 5

Name of the Condition

• Maternal care for Anti-A sensitization, first trimester, fetus 5
• ICD Code: O36.1115

Summary

This condition involves medical care and monitoring provided to a pregnant woman with anti-A sensitization during the first trimester, specifically for a pregnancy with five fetuses. The care focuses on managing potential risks to the fetuses and ensuring maternal health, particularly addressing the risk of hemolytic disease of the fetus and newborn (HDFN).

Causes

Anti-A sensitization occurs when an individual with type O blood is exposed to A or AB blood, triggering the production of anti-A antibodies. In pregnancy, this exposure may happen if the fetuses have A or AB blood type, and fetal-maternal blood mixing occurs, leading the mother's immune system to produce antibodies that may cross the placenta and affect the fetuses.

Risk Factors

• Previous pregnancy with an A or AB blood type fetus
• Blood transfusion with A or AB blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., chorionic villus sampling)
• Prior miscarriage or ectopic pregnancy involving an A or AB blood type fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn (if born)

Diagnosis

Blood typing and antibody screening to detect anti-A antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Amniocentesis or cordocentesis may be used to evaluate fetal blood status.

Treatment Options

• Close monitoring of maternal and fetal health
• Possible administration of intravenous immunoglobulin (IVIG)
• In severe cases, intrauterine transfusion for affected fetuses
• Delivery planning based on fetal and maternal condition

Prognosis and Follow-Up

Prognosis depends on the severity of sensitization and fetal response. Regular follow-up with obstetric and maternal-fetal medicine specialists is essential to monitor for complications and adjust care as needed.

Complications

• Severe fetal anemia
• Hydrops fetalis
• Preterm birth
• Increased risk of neonatal jaundice or kernicterus

Lifestyle & Prevention

• Avoid unnecessary blood exposure (e.g., untested transfusions)
• Use precautions during invasive procedures to minimize fetal-maternal blood mixing
• Follow prenatal care guidelines to detect and manage sensitization early

When to Seek Professional Help

Seek immediate medical attention if experiencing abdominal pain, bleeding, or reduced fetal movement, or if monitoring indicates concerning changes in fetal status.

Tips for Medical Coders

Document the number of fetuses (five) and the trimester (first) clearly. Ensure the anti-A sensitization is confirmed and linked to the pregnancy. Include details of monitoring, interventions, and any complications related to the condition.